title: Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study.
abstract: Women with thrombophilia and a history of recurrent pregnancy loss have poor pregnancy outcomes. Prophylaxis with enoxaparin 40 mg/day or 80 mg/day resulted in favorable gestational and neonatal outcomes.
authors.affiliation: Rambam Medical Center, Haifa, Israel. b_brenner@rambam.health.gov.il
authors.forename: Benjamin
authors.initials: B
authors.lastname: Brenner
authors.forename: Jacob
authors.initials: J
authors.lastname: Bar
authors.forename: Martin
authors.initials: M
authors.lastname: Ellis
authors.forename: Ilan
authors.initials: I
authors.lastname: Yarom
authors.forename: David
authors.initials: D
authors.lastname: Yohai
authors.forename: Aaron
authors.initials: A
authors.lastname: Samueloff
mesh_terms: D000026:Abortion, Habitual / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D017984:Enoxaparin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D050498:Live Birth / Q000453:epidemiology*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D011256:Pregnancy Outcome / Q000453:epidemiology; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data*; D019851:Thrombophilia / Q000188:drug therapy* / Q000453:epidemiology
chemical_list: D017984:Enoxaparin